ArticleOncotarget2018

Temozolomide, sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cells.

Sanford P C Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.